Pricing Log in Create free account

Artiva Biotherapeutics, Inc. (ARTV) vs Contineum Therapeutics, Inc. (CTNM)

Artiva Biotherapeutics, Inc. and Contineum Therapeutics, Inc. are both Biotechnology companies. Artiva Biotherapeutics, Inc. and Contineum Therapeutics, Inc. are of similar size ($297.2M and $296.3M). Across the 9 metrics below, Contineum Therapeutics, Inc. leads on 5 and Artiva Biotherapeutics, Inc. on 4.

Valuation

Metric ARTV CTNM Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.66 1.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.27 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (56.41%) (24.64%) (33.15%)
Free cash flow yield (33.36%) (20.33%) (25.50%)

Profitability

Metric ARTV CTNM Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.58%) (28.01%) (56.36%)
Return on assets (33.76%) (26.57%) (48.04%)
Return on invested capital 0.00% (1,334.41%) 0.00%

Growth

Metric ARTV CTNM Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 40.96% 0.46% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric ARTV CTNM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 24.16 37.17 4.72
Net debt to EBITDA 1.24 3.88 0.96

Dividend

Metric ARTV CTNM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARTV CTNM Biotechnology median
Market cap 296.27m 297.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack